Evidence map›Paper›PMID 41007765›Full record

ArticleBiomedicines2025

Integrated Virtual Screening for Anti-Caries Compounds from Neem: Dual-Target Inhibition of Biofilm Formation and Bacterial DNA Replication.

Oluwaseun E Agboola, Oluwatimileyin Agboola, Zainab A Ayinla, Samuel S Agboola, Oluranti E Olaiya, Oluwatoyin M Oyinloye, Omotola M Fajana, Olajumoke Tolulope Idowu, Olaposi I Omotuyi, Olutosin S Ilesanmi and 1 more

Abstract read
In one paragraph

Article in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Oluwaseun E AgboolaInstitute for Drug Research and Development, Bogoro Research Centre, Afe Babalola University, P.M.B 5454, Ado-Ekiti 360001, Nigeria.ORCID 0000-0002-6794-4749
Oluwatimileyin AgboolaDental Clinic Unit, Babcock University Teaching Hospital, Ilishan-Remo 121103, Nigeria.
Zainab A AyinlaDepartment of Biology, University of Waterloo, Waterloo, ON M5V 3L9, Canada.
Samuel S AgboolaDepartment of Pharmacology and Toxicology, College of Pharmacy, Afe Babalola University, Ado-Ekiti 360001, Nigeria.ORCID 0000-0003-3971-9891
Oluranti E OlaiyaDepartment of Medical Biochemistry, College of Medicine and Health Sciences, Afe Babalola University, Ado-Ekiti 360001, Nigeria.
Oluwatoyin M OyinloyeDepartment of Biological Sciences, College of Sciences, Afe Babalola University, P.M.B 5454, Ado-Ekiti 360001, Nigeria.
Omotola M FajanaInstitute for Drug Research and Development, Bogoro Research Centre, Afe Babalola University, P.M.B 5454, Ado-Ekiti 360001, Nigeria.
Olajumoke Tolulope IdowuIndustrial Chemistry Unit, Department of Chemical Sciences, College of Sciences, Afe Babalola University, Ado-Ekiti 360001, Nigeria.
Olaposi I OmotuyiInstitute for Drug Research and Development, Bogoro Research Centre, Afe Babalola University, P.M.B 5454, Ado-Ekiti 360001, Nigeria.
Olutosin S IlesanmiDepartment of Chemical Sciences, Achievers University, Owo 341101, Nigeria.
Babatunji E OyinloyeInstitute for Drug Research and Development, Bogoro Research Centre, Afe Babalola University, P.M.B 5454, Ado-Ekiti 360001, Nigeria.ORCID 0000-0003-2165-7936

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

dental cariesDNA gyrase Bdual targetingglucansucraseneem compoundsStaphylococcus aureus

Identifiers

PMID41007765
PMCPMC12467156

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.